Residency · Sioux Falls, SD
Sponsored by University of South Dakota School of Medicine
The Clinical Pharmacogenetics Implementation Consortium Guideline for SLCO1B1, ABCG2, and CYP2C9 genotypes and Statin-Associated Musculoskeletal Symptoms.
Clinical pharmacology and therapeutics · 2022 · 281 citations · Eric Larson
Criteria for Defining Stages of Cardiogenic Shock Severity.
Journal of the American College of Cardiology · 2022 · 266 citations · Wissam Khalife
Ruxolitinib Versus Best Available Therapy for Polycythemia Vera Intolerant or Resistant to Hydroxycarbamide in a Randomized Trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2023 · 137 citations · Isaak Ailts
Multiple Myeloma, Version 5.2026, NCCN Clinical Practice Guidelines In Oncology.
Journal of the National Comprehensive Cancer Network : JNCCN · 2026 · 26 citations · Noura Elsedawy
Second primary malignancies after commercial CAR T-cell therapy: analysis of the FDA Adverse Events Reporting System.
Blood · 2024 · 138 citations · Moataz Ellithi
Multiple Myeloma, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology.
Journal of the National Comprehensive Cancer Network : JNCCN · 2023 · 137 citations · Noura Elsedawy
NCCN Guidelines® Insights: Multiple Myeloma, Version 3.2022.
Journal of the National Comprehensive Cancer Network : JNCCN · 2022 · 174 citations · Noura Elsedawy
Safety, tolerability, and immunogenicity of an adult pneumococcal conjugate vaccine, V116 (STRIDE-3): a randomised, double-blind, active comparator controlled, international phase 3 trial.
The Lancet. Infectious diseases · 2024 · 57 citations · Muhammad Waleed